Clinical Social Workers in Loomis, CA Accepting Medicare

5 Clinical Social Workers found. Showing 1 - 5

Mrs. Amanda Jewell Knapp, MSW, ASW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 3725 Taylor Rd, Loomis, CA 95650 Phone: 916-652-5814

Mrs. Jessica Marguerite Miller, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 3725 Taylor Rd, Loomis, CA 95650 Phone: 916-652-5814

Jilleen Jarrett, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 7280 Starkview Pl, Loomis, CA 95650 Phone: 916-675-3887

Farrah J Hoekstra, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 3195 Humphrey Rd, Loomis, CA 95650 Phone: 559-589-4242

Ms. Patricia Alexandra Green, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 3805 Taylor Rd, Suite 1, Loomis, CA 95650 Phone: 916-652-7470    Fax: 916-652-7065

News Archive

Walgreens to pay $35 million to settle Medicaid prescription drug fraud allegations

Walgreen Co. of Deerfield, Ill., has agreed to pay $35 million to settle claims that from 2001 to 2005, it improperly switched patients to different versions of the prescriptions drugs Ranitidine, Fluoxetine and Eldepryl in order to increase its reimbursement from Medicaid, the Justice Department announced today.

Unique immunochemotherapy approach to treating pancreatic cancer

VCU Massey Cancer Center and VCU Institute of Molecular Medicine researchers discovered a unique approach to treating pancreatic cancer that may be potentially safe and effective. The treatment method involves immunochemotherapy - a combination of chemotherapy and immunotherapy, which uses the patient's own immune system to help fight against disease.

Researchers discover how metal beryllium triggers deadly immune response in the lungs

Using exquisitely detailed maps of molecular shapes and the electrical charges surrounding them, researchers at National Jewish Health have discovered how the metal beryllium triggers a deadly immune response in the lungs.

FDA approves BELSOMRA® (suvorexant) for the treatment of insomnia

Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today that the U.S. Food and Drug Administration (FDA) has approved BELSOMRA® (suvorexant) for adults with insomnia who have difficulty falling asleep and/or staying asleep. BELSOMRA (pronounced bell-SOM-rah) is a highly selective antagonist for orexin receptors.

Regis College and MGH Institute team up to offer new research-based reading courses

To help alleviate a local and nationwide shortage of teachers with expertise in reading, Regis College in Weston and MGH Institute of Health Professions in Boston have created a new partnership in which graduates will receive a Master of Arts in Teaching with a concentration in reading.

Read more Medical News

› Verified 6 days ago